Literature DB >> 16514253

Combined multimodal approach to the treatment of metastatic anal carcinoma: report of a case and review of the literature.

Margarita Tokar1, Dmitri Bobilev, Svetlana Zalmanov, David B Geffen, Shlomo Walfisch.   

Abstract

BACKGROUND: We report on a patient with squamous cell anal carcinoma and liver metastases, who underwent multimodal treatment for cure, consisting of repeated partial hepatectomy in combination with chemoradiotherapy. PATIENTS AND METHODS: A 54-year-old woman presented with squamous cell anal carcinoma and liver metastases. She was treated with a combination of chemoradiotherapy for the primary tumor and then underwent surgery for liver metastases. 2 and 5 years after presentation, the patient underwent repeated partial hepatectomies for recurrent liver disease. At present, 5 months after completing therapy and 71 months after the initial diagnosis, she is in good health with no evidence of disease.
RESULTS: Repeated partial hepatectomy led to prolonged survival in a patient with squamous cell anal carcinoma metastatic to the liver.
CONCLUSIONS: This is the first report of aggressive partial hepatectomy for recurrent liver metastases resulting from anal cancer. Based on our experience, we suggest that in selected patients repeated hepatectomy should be part of an aggressive multimodal treatment program with curative intent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16514253     DOI: 10.1159/000089798

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  10 in total

Review 1.  Pharmacotherapy of Anal Cancer.

Authors:  Jane E Rogers; Cathy Eng
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  Anal cancer - a review.

Authors:  Sajad Ahmad Salati; Azzam Al Kadi
Journal:  Int J Health Sci (Qassim)       Date:  2012-06

3.  Successful hepatectomy for metastatic squamous cell carcinoma of the anal canal-a case report.

Authors:  Tercia Tarciane Sousa; Bruna do Nascimento Santos; Marcos Belotto; Renata D'Alpino Peixoto
Journal:  J Gastrointest Oncol       Date:  2016-12

4.  Definitive chemoradiation in oligometastatic squamous cell carcinoma of the anal canal.

Authors:  Jane E Rogers; Christopher H Crane; Prajnan Das; Marc Delclos; M Spencer Gould; Aki Ohinata; Daniel Malatek; Cathy Eng
Journal:  Gastrointest Cancer Res       Date:  2014-03

Review 5.  A Patient with HIV-Associated Metastatic Anal Squamous Cell Carcinoma Receiving Multimodality Therapy with Curative Intent: Case Report and Review of the Literature.

Authors:  Sunhee S Kim; Grace E Kim; Andrew H Ko
Journal:  J Gastrointest Cancer       Date:  2017-03

Review 6.  Anal cancer treatment: current status and future perspectives.

Authors:  Marwan Ghosn; Hampig Raphael Kourie; Pamela Abdayem; Joelle Antoun; Dolly Nasr
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

7.  Stage IV anal canal squamous cell carcinoma with long-term survival: a case report.

Authors:  Katsuji Sawai; Takanori Goi; Noriyuki Tagai; Hidetaka Kurebayashi; Mitsuhiro Morikawa; Kenji Koneri; Masato Tamaki; Makoto Murakami; Yasuo Hirono; Hiroyuki Maeda
Journal:  Surg Case Rep       Date:  2022-06-20

8.  Treatment options in metastatic squamous cell carcinoma of the anal canal.

Authors:  Cathy Eng; Priyanka Pathak
Journal:  Curr Treat Options Oncol       Date:  2009-05-29

9.  A combined modality therapeutic approach to metastatic anal squamous cell carcinoma with systemic chemotherapy and local therapy to sites of disease: case report and review of literature.

Authors:  Rosana Gnanajothy; Graham W Warren; Sherry Okun; Lindsay L Peterson
Journal:  J Gastrointest Oncol       Date:  2016-06

10.  Efficacy of Cetuximab in Combination with FOLFIRI in a Patient with KRAS Wild-Type Metastatic Anal Cancer.

Authors:  Hanna Barmettler; Paul Komminoth; Mathias Schmid; Donat Duerr
Journal:  Case Rep Oncol       Date:  2012-08-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.